Journal article
Emerging Anticoagulant Drugs
Abstract
The limitations of traditional anticoagulants, heparin and warfarin, have prompted the development of new anticoagulant drugs for prevention and treatment of both venous and arterial thromboembolism. After a brief review of thrombogenesis and its regulation, this study focuses on new anticoagulant agents in more advanced stages of clinical testing.
Authors
Bates SM; Weitz JI
Journal
Arteriosclerosis Thrombosis and Vascular Biology, Vol. 23, No. 9, pp. 1491–1500
Publisher
Wolters Kluwer
Publication Date
September 2003
DOI
10.1161/01.atv.0000084827.77945.66
ISSN
1079-5642